For a non-scientific person, is the below understanding correct?
Disease control - Not getting worse, but not getting better
Partial response - Some improvement to the disease
Complete response - Disease eradicated
Secondly, is this common to see in phase 1 dose escalation studies? Where we may progress from disease control to pr/cr as dosage is upped?
Finally, would we have expected the disease to progress negatively in these patients in the absence of receiving this dosage? If so, is this an initial clue on efficacy?
Cheers
For a non-scientific person, is the below understanding...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $20.21K | 5.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2213046 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 13437123 | 19 |
View Market Depth
| Last trade - 15.01pm 24/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |